Game Plan Financial Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-100
Closed -$5.55K 377
2025
Q3
$5.55K Hold
100
﹤0.01% 243
2025
Q2
$6.9K Hold
100
﹤0.01% 236
2025
Q1
$6.94K Hold
100
﹤0.01% 236
2024
Q4
$8.56K Sell
100
-447
-82% -$48.3K ﹤0.01% 236
2024
Q3
$65.1K Hold
547
0.03% 137
2024
Q2
$78.1K Hold
547
0.04% 133
2024
Q1
$70.2K Buy
547
+197
+56% +$23.5K 0.04% 142
2023
Q4
$36.2K Buy
+350
New +$34.6K 0.02% 164

Other funds holding NVO

Game Plan Financial Advisors's NVO Position: Q4 2025 in Review

Game Plan Financial Advisors sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 100 shares — an estimated $5.55K sold.

Game Plan Financial Advisors first reported a position in NVO in Q4 2023 and held it in 8 quarters. The position peaked at $78.1K in Q2 2024. 1,414 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Game Plan Financial Advisors reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Game Plan Financial Advisors sold 100 Novo Nordisk shares in Q4 2025, an estimated $5.55K.
  • Game Plan Financial Advisors first reported a position in Novo Nordisk in Q4 2023 and held it in 8 quarters.
  • Game Plan Financial Advisors's Novo Nordisk position peaked at $78.1K in Q2 2024.
  • 1,414 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Game Plan Financial Advisors's 13F filing for Q4 2025, filed 14 Jan 2026.